Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hyd...
Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
About this item
Full title
Author / Creator
Publisher
Germany: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal-recessive disease causing cortisol deficiency, aldosterone deficiency and hyperandrogenism. Diagnosis of 21-OHD is confirmed by steroid analysis in newborn screening or later on. Standard medical treatment consists of oral glucocorticoid and mineralocorti...
Alternative Titles
Full title
Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_69095845
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69095845
Other Identifiers
ISSN
1389-9155
E-ISSN
1573-2606
DOI
10.1007/s11154-007-9053-1
